Newsroom
Inflammatix in the news
Artificial Intelligence for Clinical Decision Support in Sepsis
May 13, 2021
Inflammatix Checks off All the Right Boxes with Investors
March 19, 2021
Inflammatix nets $102M to advance its immune system tests for infectious diseases
March 16, 2021
Infection-detection system from Peninsula company scores $102M, aims to hit market this year
March 16, 2021
A Bright Future Ahead for Novel Markers of Infection
December 15, 2020
Inflammatix Awarded $7.4M in Additional BARDA Funding for POC System, Acute Infection Test
October 29, 2020
Inflammatix Moving Into Coronavirus Test Market With Gene Expression Host Response Platform
October 8, 2020
Machine Learning-Based Rapid Diagnostic Reads Immune System to Predict COVID-19 Severity Risk
September 30, 2020
Press releases
October 29, 2020
Inflammatix Announces $7.4 Million in Additional BARDA Funding to Advance ViraBac EZ Acute Infection Test
September 29, 2020
DARPA Awards Inflammatix up to $1.1 Million to Develop Diagnostic that Predicts COVID-19 Severity Risk
April 29, 2020
Study Demonstrates Substantial Cost Savings in Health Economic Model of the Inflammatix Host-Response Test for Sepsis
April 16, 2020
Inflammatix Appoints João Fonseca, Ph.D., as Chief Technology Officer
March 18, 2020
Leading Stanford Alumni Scientists and Physicians Launch StartX Med COVID-19 Task Force
March 4, 2020
New Inflammatix Study in Nature Communications Outlines Breakthrough in Diagnosing Acute Infections by Reading the Immune System
January 10, 2020
Inflammatix Announces $32 Million in Series C Funding
November 14, 2019
Inflammatix Announces Funding from BARDA to Advance HostDx™ Tests
Machine learning blogs
Podcasts
Diagnosing Infection with Ljubomir Buturovic from Inflammatix
December 2023
Advances in Sepsis Diagnostics: the HostDx Sepsis Platform
May 2018